Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment

BACKGROUND: Breast cancer is the most common malignant disease amongst Western women. The lack of treatment options for patients with chemotherapy-resistant or recurrent cancers is pushing the field toward the rapid development of novel therapies. The use of oncolytic viruses is a promising approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourgeois-Daigneault, Marie-Claude, St-Germain, Lauren Elizabeth, Roy, Dominic Guy, Pelin, Adrian, Aitken, Amelia Sadie, Arulanandam, Rozanne, Falls, Theresa, Garcia, Vanessa, Diallo, Jean-Simon, Bell, John Cameron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977613/
https://www.ncbi.nlm.nih.gov/pubmed/27503504
http://dx.doi.org/10.1186/s13058-016-0744-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977613/
https://www.ncbi.nlm.nih.gov/pubmed/27503504
http://dx.doi.org/10.1186/s13058-016-0744-y

Ejemplares similares